LOS ANGELES, CALIFORNIA / ACCESS Newswire / October 23, 2025 / Today, eXoZymes Inc. (NASDAQ:EXOZ) ("eXoZymes") - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced that CEO, Michael Heltzen, will present at the 2025 ThinkEquity Conference on October 30, 2025, at the Mandarin Oriental Hotel in New York City.

CEO of eXoZymes, Michael Heltzen, states, "Most investors already know that - compared to the number of dollars invested - synthetic biology unfortunately has very little to show for it because it never scaled commercially. That's why we have introduced the next generation of biomanufacturing - a groundbreaking new way of making chemicals by using AI to convert enzymes to function cel

See Full Page